CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,923,078
- in 11 filings, $11.2M under 10b5-1 plans
Net −$33,923,078. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-05 | Nisen Perry Director | Grant or award · Restricted Share Units | +14,492 | 14,492 | ||
| 2025-06-05 | LIEBERMAN GERALD M Director | Grant or award · Restricted Share Units | +14,492 | 14,492 | ||
| 2025-06-05 | Elstein Amir Director | Grant or award · Restricted Share Units | +14,492 | 14,492 | ||
| 2025-06-05 | Crane Rosemary A Director | Grant or award · Restricted Share Units | +14,492 | 14,492 | ||
| 2025-06-05 | Lichtenstein Chen Director | Grant or award · Restricted Share Units | +14,492 | 14,492 | ||
| 2025-06-05 | BARER SOL J Director | Grant or award · Restricted Share Units | +21,739 | 21,739 | ||
| 2025-06-05 | MIGNONE ROBERTO Director | Grant or award · Restricted Share Units | +14,492 | 14,492 | ||
| 2025-06-05 | Francis Richard D President and CEO | Grant or award · Restricted Share Units | +52,173 | 52,173 | ||
| 2025-06-03 | Shields Matthew EVP, Global Operations | Option exercise | +16,195 | 16,195 | ||
| 2025-06-03 | Shields Matthew EVP, Global Operations | Sale | −6,206 | $17.02 | $106K | 9,989 |
| 2025-06-03 | Shields Matthew EVP, Global Operations | Option exercise · Restricted Share Units | −16,195 | 48,587 | ||
| 2025-05-14 | Lippman Evan EVP, Business Development | Grant or award · Restricted Share Units | +47,365 | 47,365 | ||
| 2025-05-14 | Lippman Evan EVP, Business Development | Grant or award · Restricted Share Units | +148,016 | 148,016 | ||
| 2025-05-08 | Sabag Mark See "Remarks" | Sale | −337,915 | $18.04 | $6.1M | 150,996 |
| 2025-03-05 | Weiss Amir Chief Accounting Officer | Option exercise | +3,566 | 30,250 | ||
| 2025-03-05 | Weiss Amir Chief Accounting Officer | Option exercise · Restricted Share Units | −3,566 | 0 | ||
| 2025-03-05 | Weiss Amir Chief Accounting Officer | Grant or award · Restricted Share Units | +14,150 | 14,150 | ||
| 2025-03-05 | Fox Christine EVP, Head of U.S. Commercial | Grant or award · Restricted Share Units | +71,278 | 71,278 | ||
| 2025-03-05 | McAvoy David R. EVP, Chief Legal Officer | Grant or award · Restricted Share Units | +56,603 | 56,603 | ||
| 2025-03-05 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise | +21,390 | 459,063 |
Page 14 of 76 · 1,517 trades